New York City, NY – According to filings with the U.S. Securities and Exchange Commission, Koneksa Health is raising $15,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Christopher Benko played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Koneksa Health

Koneksa Health is the leader in developing and implementing patient-focused digital biomarkers for drug development. By unlocking the potential of real-world data from remote, wearable, and other digital technologies, Koneksa speeds up the time required to understand how a drug is working, requiring fewer patients, and develops real-world evidence for how medicines can impact patients’ daily lives.

To learn more about Koneksa Health, visit http://www.koneksahealth.com/

Contact:
Christopher Benko, President and Chief Executive Officer
855-908-4566
https://www.linkedin.com/in/cbenko/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved